Resistance to Apoptosis Induced by Serum Depletion and All-Trans Retinoic Acid in Drug-Resistant Leukemic Cell Lines

References

• Kaufman S.H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs A cautionary note. Cancer Res. 1989; 49: 5870–5878
   PubMed Web of Science ®Google Scholar
• Frankfurt O.S., Seckinger D., Sugarbaker E.V. Apoptosis and growth inhibition in sensitive and resistant leukemic cells treated with anticancer drugs. Int. J. Onco. 1994; 4: 481–489
   PubMed Web of Science ®Google Scholar
• Frankfurt O.S., Seckinger D., Sugarbaker E.V. Pleiotropic drug resistance and survival advantage in leukemic cells with deminished apoptotic response. Inr. J. Cancer 1994; 59: 217–224
   PubMed Web of Science ®Google Scholar
• Robertson L.R., Chubb S., Meyn R.E., Story M., Ford R., Hittelman W.N., Plunkett W. Induction of apoptotic cell death in chronic lympbocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine. Blood 1993; 81: 143–150
   PubMed Web of Science ®Google Scholar
• Kakihara T., Yamada T., Fukuda T., Ohnishi Y., Kishi K., Uchiyama M., Sbibata A. Induction of surface antigen recognized by new monoclonal antibody, YU311, on 1-β-D-arabinofuranosylcytosine-resistant human leukemic cell line. Leukemia Res. 1993; 17: 541–545
   PubMed Web of Science ®Google Scholar
• Kobayashi T., Kakihara T., Uchiyama M., Fukuda T., Kishi K., Shibata A. Low expression of the deoxycytidine kinase (dCK) gene in a 1-β-D-arabinofuranosylcytosine-resistant human leukemic cell line. KY-Ra. Leukemia and Lymphoma 1994; 15: 503–505
   PubMed Web of Science ®Google Scholar
• Kakihara T., Yamada T., Fukuda T., Ohnishi Y., Kishi K., Shibata A. Vincristine-resistant human leukemia cell line: new monoclonal antibodies to a 65kDa membrane protein. Leukemia and Lymphoma 1992; 7: 157–164
   PubMed Web of Science ®Google Scholar
• Fukuda T., Kakihara T., Kamishima T., Ohnishi Y., Naito M., Kishi K., Shibata A., Tsuruo T. Characterization of newly established adriamycin resistant human leukemic cell lines (KY-ADR1 and KY-ADR2). Leukemia Res. 1994; 18: 709–715
   PubMed Web of Science ®Google Scholar
• Saito H., Kishi K., Narita M., Furukawa T., Nagura E., Maekawa T., Abe T., Shibata A. A new myeloblastic leukemia cell line with double minute chromosomes, induction of methothrexate resistance and dihydrofolate reductase gene amplification. Leukemia Res. 1992; 16: 217–226
   PubMed Web of Science ®Google Scholar
• Green L.M., Reade J.L., Ware C.W. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J. Immunol. Methods 1984; 70: 257–268
   PubMed Web of Science ®Google Scholar
• Smets L.A., Berg J.V., Acton D., Top B., Rooiji H.V., Verwijs-Janssen M. Bcl-2 expression and Mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid-induced apoptosis. Blood 1994; 84: 1613–1619
   PubMed Web of Science ®Google Scholar
• Martin S.J., Bradley J.G., Cotter T.G. HL-60 cells induced to differentiate toward neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 1990; 79: 448–453
   PubMed Web of Science ®Google Scholar
• Falcieri E., Martelli A.M., Bareggi R., Cataldi A., Cocco L. The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in Molt-4 cells without concomitant DNA fragmentation. Biochem. Biophys. Res. Comm. 1993; 193: 19–25
   PubMed Web of Science ®Google Scholar
• Shaw P., Bovey R., Tardy S., Sahli R., Sordat B., Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor—derived cell line. Proc. Natl. Acad. Sci. USA 1992; 89: 4495–4499
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation -competent and -defective myeloid leukemic cells. Cell Growth Differ. 1993; 4: 41–47
   PubMedGoogle Scholar
• Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-FAS) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989; 169: 1747–1756
   PubMed Web of Science ®Google Scholar
• Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440–442
   PubMed Web of Science ®Google Scholar
• Evans G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 69: 119–128
   PubMed Web of Science ®Google Scholar
• Chin K.V., Ueda K., Pastan I., Gottesman M.M. Modulation of activity of the promoter of the human mdrl gene by ras and p53. Science 1992; 255: 459–462
   PubMed Web of Science ®Google Scholar
• Goker E., Waltham M., Kheradpour A., Trippett T., Mazumdar M., Elisseyeff Y., Schnieders B., Steinherz P., Tan C., Berman E., Bertino J.R. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood 1995; 86: 677–684
   PubMed Web of Science ®Google Scholar
• Fukuda T., Kakihara T., Kamishima T., Ohnishi Y., Naito M., Kishi K., Shibata A. Different effects of various hematopoietic growth factors on myelomonocytic cell line (KY-821) and its drug-resistant sublines. Leukemia Res. 1993; 17: 325–332
   PubMed Web of Science ®Google Scholar